|
|
|
|
LEADER |
02003nam a22003375i 4500 |
001 |
978-1-4615-0593-8 |
005 |
20191022002614.0 |
007 |
cr nn 008mamaa |
008 |
121227s2002 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781461505938
|
024 |
7 |
|
|a 10.1007/978-1-4615-0593-8
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Iron Chelation Therapy
|c edited by Chaim Hershko.
|
250 |
|
|
|a 1st ed. 2002.
|
260 |
# |
# |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 2002.
|
300 |
|
|
|a VIII, 277 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|v 509
|
505 |
0 |
|
|a Pathopysiology of Iron Overload -- 1.Animal Models of Hereditary Iron Transport Disorders -- 2.Mechanism of Iron Toxicity -- 3.Role of Non-Transferrin-Bound Iron in the Pathogenesis of Iron Overload and Toxicity -- 4.Intacellular and Extracellular Labile Iron Pools -- 5.Cardioprotective Effect of Iron Chelators -- Chelation Therapy in Transfulional Siderosis -- 6.Results of Long Term Iron Chelation Treatment with Deferoxamine -- 7.Long Term Deferiprone Chelation Therapy -- Development of New Iron Chelators -- 8.Iron Chelator Chemistry -- 9.Structure-Activity Relationships Among Desazadesferrithiocin Analogues -- 10.ICL670A: Preclinical Profile -- 11.Pyridoxal Isonicotinoyl Hydrazone and Its Analogues -- Novel Strategies in Iron Chelation Treatment -- 12.Therapeutic Potential of Iron Chelators in Cancer Therapy -- 13.Antimalarial Effect of Iron Chelators.
|
650 |
|
0 |
|a Inorganic chemistry.
|
650 |
|
0 |
|a Hematology.
|
650 |
|
0 |
|a Veterinary medicine.
|
650 |
1 |
4 |
|a Inorganic Chemistry.
|
650 |
2 |
4 |
|a Hematology.
|
650 |
2 |
4 |
|a Veterinary Medicine/Veterinary Science.
|
700 |
1 |
|
|a Hershko, Chaim.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4615-0593-8
|